Atlas Trials

Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder

Clinical trial NCT01382719 · COMPLETED

Trial details

NCT number
NCT01382719
Sponsor
Palatin Technologies, Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Female Sexual Arousal DisorderHypoactive Sexual Desire Disorder
Start date
2011-06-01
Primary completion
2012-09-01
Enrollment
612

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.